PCV117 Clinical and Patient-Reported Outcomes of Triple Combination of Olmesartan Medoxomil (OM), Amlodipine Besylate (AML) and Hydrochlorothiazide (HCT) in Hypertensive Patients
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.837
https://www.valueinhealthjournal.com/article/S1098-3015(11)02399-0/fulltext
Title :
PCV117 Clinical and Patient-Reported Outcomes of Triple Combination of Olmesartan Medoxomil (OM), Amlodipine Besylate (AML) and Hydrochlorothiazide (HCT) in Hypertensive Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02399-0&doi=10.1016/j.jval.2011.08.837
First page :
A385
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
800